21:59 , Aug 12, 2019 |  BC Extra  |  Politics & Policy

Aug. 12 P&P Quick Takes: China to implement ethics committee; plus Senators call for action on AveXis and FDA’s Fabry guidance

China planning national science, technology ethics committee  China’s central committee for deepening overall reform approved a plan to establish a national science and technology ethics committee. The government said the committee is meant to improve...
02:33 , Jul 13, 2019 |  BioCentury  |  Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

The performance of 1H19 IPOs point toward a continuation of a dual-class system where biotechs backed by deep-pocketed VCs and crossover investors can tap the public market at will and generate stronger after-market performance than...
21:59 , Jul 11, 2019 |  BC Innovations  |  Targets & Mechanisms

The tumor stroma rises as the newest source of immuno-oncology targets

With a spate of therapies entering the clinic, the next frontier in the fight against resistance to checkpoint inhibitors will be the stroma. The lead target marks a resurgence of interest in TGFβ, and behind...
00:43 , Jun 14, 2019 |  BC Extra  |  Company News

Tessa forms JV with biohub to bring its cell therapies to China

Tessa is hoping a JV with a Guangzhou biohub will speed access to the company’s virus-specific T cell therapies for cancers prevalent in China. The Singapore-based company, which partnered Thursday with GSGKC to develop and...
14:28 , Mar 19, 2019 |  BC Innovations  |  Distillery Therapeutics

RSV F protein-based nanoparticle vaccine for RSV infection

DISEASE CATEGORY: Infectious disease INDICATION: Respiratory syncytial virus (RSV) Mouse and non-human primate studies suggest an RSV F protein-based nanoparticle vaccine could help prevent RSV infection. The self-assembling nanoparticles consist of a core of 12...
00:33 , Mar 5, 2019 |  BC Extra  |  Financial News

Shanghai exchange eases rules for biopharmas listing on new innovation board

Revised rules for a new science and technology board loosen requirements for biopharma and tech companies seeking to list on the Shanghai Stock Exchange. Implemented March 1, the rules update draft rules released Jan. 29...
17:11 , Feb 28, 2019 |  BC Week In Review  |  Financial News

Gracell raises $85M series B to advance cell therapies

Temasek led an $85 million series B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China) that closed Feb. 25. Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji also participated...
21:39 , Feb 25, 2019 |  BC Extra  |  Financial News

Gracell raises $85M series B to advance cell therapies

Temasek led an $85 million series B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji also participated in the round. Gracell,...
18:54 , Feb 15, 2019 |  BC Week In Review  |  Clinical News

Cellular BioMedicine to test stem cell therapy in Chinese Phase II for knee osteoarthritis

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) said China's National Medical Products Administration (NMPA) approved an IND for a Phase II trial of AlloJoin to treat knee osteoarthritis. The product is an allogeneic adipose-derived mesenchymal progenitor cell...
19:44 , Feb 1, 2019 |  BC Week In Review  |  Clinical News

NIAID says its Ebola therapy is safe

The National Institute of Allergy and Infectious Diseases Vaccine Research Center said IV infusions of its Ebola therapy mAb114 were well tolerated in the open-label, U.S. Phase I VRC 608 trial in 18 healthy adults....